Liver Enzyme Abnormalities and Associated Risk Factors in HIV Patients on Efavirenz-Based HAART with or without Tuberculosis Co-Infection in Tanzania

• Sabina Mugusi,

  Affiliations Infectious Disease Unit, Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden, Department of Internal Medicine, Muhimbili National Hospital, Dar es Salaam, Tanzania

  ⨯
• Eliford Ngaimisi,

  Affiliations Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital-Huddinge, Karolinska Institute, Stockholm, Sweden, Unit of Pharmacology and Therapeutics, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Mohamed Janabi,

  Affiliation Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Omary Minzi,

  Affiliation Unit of Pharmacology and Therapeutics, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Muhammad Bakari,

  Affiliation Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Klaus-Dieter Riedel,

  Affiliation Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Juergen Burhenne,

  Affiliation Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany

  ⨯
• Lars Lindquist,

  Affiliation Division of Infectious Diseases, Department of Medicine, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden

  ⨯
• Ferdinand Mugusi,

  Affiliation Department of Internal Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

  ⨯
• Eric Sandstrom,

  Affiliation Infectious Disease Unit, Department of Clinical Science and Education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden

  ⨯
• Eleni Aklillu

  * E-mail: Eleni.Aklillu@ki.se

  Affiliation Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska University Hospital-Huddinge, Karolinska Institute, Stockholm, Sweden

  ⨯